Abrdn World Healthcare Fund (THW) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Abrdn World Healthcare Fund (THW) trades at $13.96 with AI Score 42/100 (Grade C). Abrdn World Healthcare Fund is a closed-end investment fund specializing in the healthcare sector. Market cap: $563M, Sector: Financial services.
Price as of Aug 21, 2026 · Last analyzed: Mar 16, 2026Analyst Coverage for THW: THW does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates THW against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
THW: 1/3 scored disciplines lean bullish. Dominant signal: Ken Griffin bearish.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Abrdn World Healthcare Fund (THW) Financial Services Profile
Abrdn World Healthcare Fund is a closed-end fund focusing on global healthcare investments, balancing equity and fixed-income assets. Managed by Tekla Capital Management, THW offers investors exposure to the healthcare sector through a diversified portfolio, distinguishing itself with a high dividend yield and a focus on long-term capital appreciation.
What Is the Investment Thesis for THW?
Abrdn World Healthcare Fund presents an investment opportunity centered on the growing global healthcare sector. With a high dividend yield of 11.59% and a beta of 0.76, THW offers income and relative stability compared to the broader market. The fund's strategy of investing in both equity and fixed-income securities provides diversification within the healthcare space. Key value drivers include the aging global population, advancements in medical technology, and increasing healthcare spending. Potential catalysts include positive clinical trial results for portfolio companies and favorable regulatory changes. However, investors may want to evaluate risks such as healthcare policy changes, competition within the sector, and potential interest rate hikes impacting fixed-income investments. The fund's high profit margin of 871.1% suggests strong profitability within its portfolio holdings.
Based on FMP financials and quantitative analysis
THW Key Highlights
Market Cap of $563M indicates THW's size and relative influence within the closed-end fund market.
- P/E Ratio of 8.5 suggests the fund's holdings are potentially undervalued compared to earnings.
- Profit Margin of 871.1% reflects the profitability of the underlying healthcare companies in THW's portfolio.
- Dividend Yield of 11.59% offers a substantial income stream for investors seeking regular payouts.
- Beta of 0.76 indicates lower volatility compared to the overall market, providing relative stability.
Who Are THW's Competitors?
THW is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ADCCX American Century Disciplined Growth Fund | $16.39 | -0.67% | $446M | 44 |
| ALZFX Alger Focus Equity Fund | $121.76 | -0.20% | $616M | 44 |
| BGB Blackstone/GSO Strategic Credit Fund | $11.27 | -0.44% | $503M | 42 |
| EWMCX Evercore Equity Fund | $44.08 | -0.99% | $534M | 44 |
| GUG Guggenheim Active Allocation Fund | $14.86 | -0.87% | $490M | 42 |
| NCDL Nuveen Churchill Direct Lending Corp. | $12.35 | +0.00% | $610M | 86 |
| SLRC SLR Investment Corp. | $12.58 | -1.18% | $686M | 92 |
| ACGP Associated Capital Group, Inc. | $33.45 | -0.06% | $698M | 67 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are THW's Key Strengths?
High dividend yield provides attractive income stream.
- Diversified portfolio across healthcare equities and fixed income.
- Managed by experienced healthcare investment firm Tekla Capital Management.
- Relatively low beta suggests lower volatility compared to the broader market.
What Are THW's Weaknesses?
Closed-end fund structure can lead to price volatility based on market sentiment.
- Gross margin is negative, indicating potential cost management issues.
- Concentration in the healthcare sector exposes the fund to sector-specific risks.
- Fund performance is highly dependent on the performance of the healthcare industry.
What Could Drive THW Stock Higher?
Positive clinical trial results for portfolio companies could drive stock prices higher.
- Increasing healthcare spending globally supports revenue growth for healthcare providers and pharmaceutical companies.
- Advancements in medical technology create new investment opportunities in innovative healthcare solutions.
- Aging global population drives demand for healthcare services and products.
What Are the Key Risks for THW?
Changes in healthcare regulations and policies could negatively impact profitability.
- Increased competition within the healthcare industry could erode market share.
- Economic downturns could reduce healthcare spending and impact fund performance.
- Interest rate hikes could negatively impact the value of fixed-income investments.
- Market volatility and geopolitical events could create uncertainty and impact investment returns.
What Are the Growth Opportunities for THW?
- Aging Global Population: The increasing proportion of elderly individuals worldwide is driving demand for healthcare services and products. This demographic shift creates a long-term growth opportunity for THW, as companies within its portfolio benefit from increased healthcare spending. The global aging population is projected to reach 1.4 billion by 2030, representing a significant market for healthcare investments.
- Advancements in Medical Technology: Continuous innovation in medical technology, including pharmaceuticals, medical devices, and biotechnology, fuels growth within the healthcare sector. THW can capitalize on these advancements by investing in companies at the forefront of innovation, driving long-term capital appreciation.
- Increasing Healthcare Spending: Healthcare spending is on the rise globally, driven by factors such as increased access to healthcare services and rising incomes in emerging markets. THW can benefit from this trend by investing in companies that provide essential healthcare services and products.
- Emerging Markets Growth: The growth of emerging markets presents a significant opportunity for THW. As these economies develop, their healthcare infrastructure improves, and access to healthcare services expands. Investing in healthcare companies operating in emerging markets can provide THW with exposure to high-growth potential. Healthcare spending in emerging markets is projected to grow at a rate of 8-10% annually.
- Strategic Acquisitions and Partnerships: Healthcare companies are increasingly engaging in strategic acquisitions and partnerships to expand their product portfolios, enter new markets, and enhance their competitive positions. THW can benefit from these activities by investing in companies that are actively involved in M&A, driving shareholder value. The global healthcare M&A market is expected to remain active, with deal values potentially reaching $400 billion annually.
What Are THW's Competitive Advantages?
- Expertise in Healthcare Sector: Tekla Capital Management's specialized knowledge and experience in the healthcare sector provide a competitive advantage in identifying and evaluating investment opportunities.
- Diversified Portfolio: The fund's diversified portfolio of healthcare-related equities and fixed-income securities reduces risk and enhances stability.
- Closed-End Structure: The closed-end structure allows the fund to invest in less liquid securities and employ strategies that may not be suitable for open-end mutual funds.
- High Dividend Yield: The fund's high dividend yield attracts income-seeking investors and provides a consistent return on investment.
What Does THW Do?
Abrdn World Healthcare Fund (THW) is a closed-end fund established on June 26, 2015, and managed by Tekla Capital Management LLC. Domiciled in the United States, the fund specializes in the healthcare sector, investing in a mix of public equity and fixed-income markets worldwide. THW's investment strategy involves identifying and investing in companies operating within the healthcare industry, aiming to capitalize on the sector's growth potential. The fund’s fixed-income component primarily consists of corporate debt securities, providing a balance to its equity holdings. As a closed-end fund, THW offers a fixed number of shares, which are traded on the open market, potentially leading to price fluctuations based on investor demand and market conditions. The fund's objective is to provide investors with both current income and long-term capital appreciation through a diversified portfolio of healthcare-related assets. Tekla Capital Management leverages its expertise in the healthcare sector to actively manage the fund's investments, seeking opportunities across various sub-sectors and geographies. THW's structure allows it to invest in less liquid securities and employ strategies that may not be suitable for open-end mutual funds. The fund's performance is influenced by factors such as healthcare industry trends, regulatory changes, and global economic conditions.
What Products and Services Does THW Offer?
- Invests in public equity markets globally.
- Invests in fixed income markets globally.
- Focuses on companies operating in the healthcare sector.
- Invests in corporate debt securities.
- Seeks to provide current income and long-term capital appreciation.
- Actively manages investments through Tekla Capital Management LLC.
How Does THW Make Money?
- The fund raises capital through the issuance of a fixed number of shares.
- It invests in a diversified portfolio of healthcare-related equities and fixed-income securities.
- The fund generates income from dividends and interest earned on its investments.
- Capital appreciation is achieved through the growth in value of its portfolio holdings.
What Industry Does THW Operate In?
Abrdn World Healthcare Fund operates within the asset management industry, specifically focusing on the healthcare sector. The global healthcare market is experiencing growth driven by factors such as an aging population, increasing prevalence of chronic diseases, and advancements in medical technology. The competitive landscape includes other healthcare-focused funds like ADCCX, ALZFX, BGB, EWMCX, and GUG, each with varying investment strategies and risk profiles. THW differentiates itself through its balanced approach of investing in both equity and fixed-income securities within the healthcare sector, offering investors a diversified exposure to this growing market.
Who Are THW's Key Customers?
- Individual investors seeking exposure to the healthcare sector.
- Institutional investors looking for income and capital appreciation.
- Retirement funds seeking diversified investment options.
- Wealth management firms seeking healthcare-focused investments for their clients.
Financial Health
Abrdn World Healthcare Fund's Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 3.48 places it in the safe zone, indicating low near-term bankruptcy risk.
How Abrdn World Healthcare Fund Is Valued
Relative to its peer group, THW's quantitative score of 42/100 is roughly in line with the peer average of 43/100.
THW Financials
Bull Case vs Bear Case
Bull Case
- High dividend yield provides attractive income stream.
- Diversified portfolio across healthcare equities and fixed income.
- Managed by experienced healthcare investment firm Tekla Capital Management.
- Relatively low beta suggests lower volatility compared to the broader market.
Bear Case
- Closed-end fund structure can lead to price volatility based on market sentiment.
- Gross margin is negative, indicating potential cost management issues.
- Concentration in the healthcare sector exposes the fund to sector-specific risks.
- Fund performance is highly dependent on the performance of the healthcare industry.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
THW Latest News
-
Stocks That Hit 52-Week Highs On Tuesday
· Dec 16, 2019
-
Stocks That Hit 52-Week Highs On Friday
· Dec 13, 2019
THW Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for THW.
Price Targets
Wall Street price target analysis for THW.
THW MoonshotScore
What does this score mean?
The MoonshotScore rates THW 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: William R. Hite
CEO
William R. Hite serves as the CEO of Tekla Capital Management LLC, the investment advisor for Abrdn World Healthcare Fund. His extensive background in financial management and investment strategy has been instrumental in guiding the fund's investment decisions. Prior to joining Tekla Capital Management, Hite held various leadership positions in the financial services industry, gaining expertise in portfolio management, asset allocation, and risk management. His educational background includes advanced degrees in finance and economics, providing a strong foundation for his role in managing the fund's investments.
Track Record: Under William R. Hite's leadership, Tekla Capital Management has successfully navigated the complexities of the healthcare sector, delivering consistent returns for investors. His strategic decisions have focused on identifying and investing in innovative healthcare companies with strong growth potential. Hite's expertise in portfolio construction and risk management has helped the fund maintain a diversified portfolio and mitigate potential losses. His tenure has been marked by a commitment to providing investors with both current income and long-term capital appreciation.
What Investors Ask About Abrdn World Healthcare Fund (THW) — Financial Services
What does the AI Score mean for THW?
THW holds an AI Score of 42/100 (Grade: C). This is an educational research signal, not a buy or sell recommendation. Abrdn World Healthcare Fund is a closed-end investment fund specializing in the healthcare sector. It invests in both equity and fixed-income securities globally.
What does Abrdn World Healthcare Fund do?
Abrdn World Healthcare Fund is a closed-end investment fund that focuses on the global healthcare sector. Managed by Tekla Capital Management LLC, the fund invests in a diversified portfolio of both equity and fixed-income securities of companies operating in the healthcare industry.
What are the main risks for THW?
The main risks for Abrdn World Healthcare Fund include regulatory changes in the healthcare sector, which could impact the profitability of portfolio companies. Increased competition among healthcare providers and pharmaceutical companies could also erode market share and profitability. Economic downturns could reduce healthcare spending, affecting the fund's performance.
How sensitive is THW to interest rate changes?
As a fund that invests in both equity and fixed-income securities, THW's performance is sensitive to interest rate changes. Rising interest rates can negatively impact the value of the fund's fixed-income holdings, as bond prices typically fall when rates increase. However, the fund's equity investments may benefit from a rising interest rate environment if it signals a strengthening economy.
What regulatory challenges does Abrdn World Healthcare Fund face?
Abrdn World Healthcare Fund faces regulatory challenges related to the healthcare and financial sectors. Changes in healthcare regulations and policies, such as drug pricing controls or insurance coverage mandates, can significantly impact the profitability of companies within the fund's portfolio. The fund is also subject to regulations governing investment companies, including those related to disclosure, compliance, and capital requirements.
What are the key factors to evaluate for THW?
Abrdn World Healthcare Fund (THW) holds an AI score of 42/100 (low). P/E: 8.5x vs the S&P 500's ~20-25x. Not financial advice.
How frequently does THW data refresh on this page?
THW's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven THW's recent stock price performance?
Abrdn World Healthcare Fund (THW) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: High dividend yield provides attractive income stream. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider THW overvalued or undervalued right now?
Abrdn World Healthcare Fund (THW) trades at 8.5x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- AI analysis pending may provide further insights.
- Financial data is based on publicly available information and may be subject to change.
- Investment decisions should be based on individual risk tolerance and financial goals.